Form 8-K CASSAVA SCIENCES INC For: Jul 01

Go back to Form 8-K CASSAVA SCIENCES INC For: Jul 01

Jones Trading Downgrades Cassava Sciences (SAVA) to Hold, 'Multiple Uncertainties'

July 1, 2024 9:43 AM EDT

Jones Trading analyst Soumit Roy downgraded Cassava Sciences (NASDAQ: SAVA) from Buy to Hold.

The analyst comments "Following the federal grand jury indictment of the former consultant of Cassava Sciences, Dr. Hoau-Yan Wang, last Friday (link), and today's 8-K (link) mentioning the... More

Cassava Sciences (SAVA) Provides Update on Government Investigations

July 1, 2024 8:09 AM EDT

Cassava Sciences (NASDAQ: SAVA) disclosed:

Item 8.01. Other Events.

Update on Government Investigations

Cassava Sciences, Inc. (Cassava or the Company) has been engaging with the U.S. Department of Justice (the DOJ) and the U.S. Securities and Exchange Commission (the SEC) in connection with ongoing investigations into the Company and two senior employees of the Company. Cassava is cooperating with the DOJ and SEC in connection with these investigations.

In the course of ongoing discussions with the SEC regarding the Companys Phase 2b study of simufilam in Alzheimers... More